Seres Therapeutics Inc (MCRB) has gained Tuesday morning, with the stock climbing 8.25% in pre-market trading to 1.05. MCRB's short-term technical score of 2 indicates that the stock has traded less bullishly over the last month than 98% of stocks on the market. In the Biotechnology industry, which ranks 124 out of 146 industries, Seres Therapeutics Inc ranks higher than 3% of stocks. Seres Therapeutics Inc has fallen 31.69% over the past month, closing at $1.54 on October 24. During this period of time, the stock fell as low as $0.93 and as high as $1.63. MCRB has an average analyst recommendation of Strong Buy. The company has an average price target of $11.25.
MCRB has an Overall Score of 31. Find out what this means to you and get the rest of the rankings on MCRB!